A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination.
Saab
S
S
Department of Medicine, Division of Digestive Diseases, University of California, Los Angeles, School of Medicine, Los Angeles, California 90095, USA.
Martin
P
P
Yee
H F
HF
D000328:Adult; D000368:Aged; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D006506:Hepatitis A / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D035922:Hepatitis A Antibodies; D022362:Hepatitis A Vaccines; D017957:Hepatitis A Virus, Human / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood; D006801:Humans; D008875:Middle Aged; D017059:Models, Econometric; D016036:Seroepidemiologic Studies; D014481:United States / Q000453:epidemiology; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000191:economics; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage* / Q000191:economics*
D035922:Hepatitis A Antibodies; D022362:Hepatitis A Vaccines; D006508:Hepatitis Antibodies; D015164:Vaccines, Inactivated; D014761:Viral Hepatitis Vaccines